Clinical Network Services   Report issue

For profit Phase 1 Phase 2
Founded: Hamilton Australia (1998)

Organization Overview

First Clinical Trial
2012
NCT01748838
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Clinical Network Services (CNS) Pty Ltd

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 1)

Influenza, Human (Phase 2)

Malaria (Phase 1)

Pneumonia (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 10